UA55645A - Способ ангиогенеза при хронической ишемии нижних конечностей - Google Patents
Способ ангиогенеза при хронической ишемии нижних конечностей Download PDFInfo
- Publication number
- UA55645A UA55645A UA2002032235A UA200232235A UA55645A UA 55645 A UA55645 A UA 55645A UA 2002032235 A UA2002032235 A UA 2002032235A UA 200232235 A UA200232235 A UA 200232235A UA 55645 A UA55645 A UA 55645A
- Authority
- UA
- Ukraine
- Prior art keywords
- treatment
- angiogenesis
- bone marrow
- lower limbs
- patients
- Prior art date
Links
- 208000028867 ischemia Diseases 0.000 title claims abstract description 12
- 210000003141 lower extremity Anatomy 0.000 title claims abstract description 11
- 238000000034 method Methods 0.000 title claims abstract description 7
- 230000033115 angiogenesis Effects 0.000 title claims abstract description 6
- 230000001684 chronic effect Effects 0.000 title claims abstract description 6
- 210000001185 bone marrow Anatomy 0.000 claims abstract description 12
- 210000002303 tibia Anatomy 0.000 claims abstract description 3
- 210000003414 extremity Anatomy 0.000 claims description 10
- 229930003270 Vitamin B Natural products 0.000 claims description 4
- 235000019156 vitamin B Nutrition 0.000 claims description 4
- 239000011720 vitamin B Substances 0.000 claims description 4
- 239000003102 growth factor Substances 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 2
- 230000000302 ischemic effect Effects 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 4
- 210000002683 foot Anatomy 0.000 description 4
- 210000002414 leg Anatomy 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000002082 fibula Anatomy 0.000 description 2
- 210000003692 ilium Anatomy 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010049927 Dry gangrene Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 230000002491 angiogenic effect Effects 0.000 description 1
- 238000002583 angiography Methods 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 238000004500 asepsis Methods 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000000459 calcaneus Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 210000001621 ilium bone Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 210000001872 metatarsal bone Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000009608 myelography Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000026341 positive regulation of angiogenesis Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000000250 revascularization Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 238000002693 spinal anesthesia Methods 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000006439 vascular pathology Effects 0.000 description 1
- 238000007631 vascular surgery Methods 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Способ ангиогенеза при хронической ишемии нижних конечностей включает в себя введение в ишемизированную конечность факторов роста. В губчатое вещество (substantia spongiosa) большеберцовой кости пораженной конечности вводят аутологичный костный мозг вместе с 500 мкг витамина В12.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2002032235A UA55645A (ru) | 2002-03-20 | 2002-03-20 | Способ ангиогенеза при хронической ишемии нижних конечностей |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2002032235A UA55645A (ru) | 2002-03-20 | 2002-03-20 | Способ ангиогенеза при хронической ишемии нижних конечностей |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA55645A true UA55645A (ru) | 2003-04-15 |
Family
ID=74207261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2002032235A UA55645A (ru) | 2002-03-20 | 2002-03-20 | Способ ангиогенеза при хронической ишемии нижних конечностей |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA55645A (ru) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2703395C1 (ru) * | 2018-10-29 | 2019-10-16 | Федеральное государственное бюджетное военное образовательное учреждение высшего образования "Военно-медицинская академия имени С.М. Кирова" Министерства обороны Российской Федерации (ВМедА) | Способ комбинированной хирургической стимуляции неоангиогенеза хронической ишемии нижних конечностей |
-
2002
- 2002-03-20 UA UA2002032235A patent/UA55645A/ru unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2703395C1 (ru) * | 2018-10-29 | 2019-10-16 | Федеральное государственное бюджетное военное образовательное учреждение высшего образования "Военно-медицинская академия имени С.М. Кирова" Министерства обороны Российской Федерации (ВМедА) | Способ комбинированной хирургической стимуляции неоангиогенеза хронической ишемии нижних конечностей |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cronenwett et al. | Limb salvage despite extensive tissue loss: free tissue transfer combined with distal revascularization | |
| Henning et al. | Platelet-rich plasma in the foot and ankle | |
| Krause et al. | Outcome of transmetatarsal amputations in diabetics using antibiotic beads | |
| Ehrlichman et al. | Common complications of wound healing: prevention and management | |
| Davlatov | The review of the form of neuropathic diabetic foot | |
| Chen et al. | Management of wounds with exposed bone structures using an artificial dermis and skin grafting technique | |
| Ou et al. | Transverse tibial bone transport enhances distraction osteogenesis and vascularization in the treatment of diabetic foot | |
| Chen et al. | Effect of tibial cortex transverse transport in patients with recalcitrant diabetic foot ulcers: A prospective multicenter cohort study | |
| Fink et al. | Wound coverage options for soft tissue defects following calcaneal fracture management (operative/surgical) | |
| Watson | Soft tissue complications following calcaneal fractures | |
| Innocenti et al. | Free perforator flaps vs propeller flaps in lower limb reconstruction: a cost/effectiveness analysis on a series of 179 cases | |
| Hahn et al. | Use of revascularized artery as a recipient in microvascular reconstruction of the lower leg: An analysis of 62 consecutive free flap transfers | |
| Chang et al. | Outcomes of integrated surgical wound treatment mode based on tibial transverse transport for diabetic foot wound | |
| JP2006232834A (ja) | 組織損傷の治療のための方法及びキット | |
| Kollrack et al. | Infected internal fixation after ankle fractures—a treatment path | |
| Liang et al. | Clinical outcomes of autologous platelet-rich plasma and bone marrow mononuclear cells grafting combined with core decompression for Association Research Circulation Osseous II–IIIA stage non-traumatic osteonecrosis of the femoral head | |
| RU2618928C1 (ru) | Способ лечения дегенеративно-дистрофических заболеваний и последствий травм опорно-двигательного аппарата | |
| RU2299700C1 (ru) | Способ выбора хирургической тактики при лечении синдрома диабетической стопы | |
| US20210023140A1 (en) | Platelet formulations and medical uses thereof | |
| UA55645A (ru) | Способ ангиогенеза при хронической ишемии нижних конечностей | |
| Jianda et al. | An novel and alternative treatment method for large heel ulceration in diabetic patients: Proximal tibial cortex transverse distraction | |
| Liu et al. | Anterior superior iliac spine distraction for severe and recalcitrant diabetic foot ulcers | |
| RU2703395C1 (ru) | Способ комбинированной хирургической стимуляции неоангиогенеза хронической ишемии нижних конечностей | |
| RU2754415C1 (ru) | Способ лечения нейроишемической формы синдрома диабетической стопы | |
| DeVries et al. | Double row fixation is more costly and does not have clinical benefit over single anchor for insertional Achilles tendon surgery |